Agios Pharmaceuticals, Inc. (0HB0.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.57B |
| Enterprise Value | 1.55B |
| P/E Ratio | -5.03 |
| PEG Ratio | -0.58 |
| Price/Sales Ratio | 13.49 |
| Price/Book Ratio | 1.94 |
| Enterprise/Revenue | 12.76 |
| Enterprise/EBITDA | -4.75 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -2.65 |
| Operating Margin | -2.98 |
AD
Management Effectiveness
| Return On Assets | -0.35 |
| Return On Equity | -0.35 |
Income Statement
| Revenue | 54.03M |
| Revenue/Share | 2.36 |
| Gross Profit | 42.51M |
| EBITDA | -466.96M |
| Net Income | -412.78M |
| Diluted EPS | -7.12 |
Balance Sheet
| Total Cash | 630.01M |
| Total Cash/Share | 10.55 |
| Total Debt | 26.53M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 9.69 |
| Book Value Per Share | 16.4 |
Price History
| 52-Week Change | -29.32 |
| 52-Week High | 45.81 |
| 52-Week Low | 22.4 |
| Moving Average 50 Days | 33.18 |
| Moving Average 200 Days | 31.74 |
Statistics
| Average Volume | 337 |
| Shares Outstanding | 58.18M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
